Abnormal expression of rno_circRNA_014900 and rno_circRNA_005442 induced by ketamine in the rat hippocampus
Open accessAbstract
BACKGROUND: Recent studies have shown that circular RNA (circRNA) is rich in microRNA (miRNA) binding sites. We have previously demonstrated that the antidepressant effect of ketamine is related to the abnormal expression of various miRNAs in the brain. This study determined the expression profile of circRNAs in the hippocampus of rats treated with ketamine. METHODS: The aberrantly expressed circRNAs in rat hippocampus after ketamine injection were analyzed by microarray chip, and we further validated these circRNAs by quantitative reverse-transcription PCR (qRT-PCR). The target genes of the different circRNAs were predicted using bioinformatic analyses, and the functions and signal pathways of these target genes were investigated by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. RESULTS: Microarray analysis showed that five circRNAs were aberrantly expressed in rat hippocampus after ketamine injection (fold change > 2.0, p < 0.05). The results from the qRT-PCR showed that one of the circRNAs was significantly increased (rno_circRNA_014900; fold change = 2.37; p = 0.03), while one was significantly reduced (rno_circRNA_005442; fold change = 0.37; p = 0.01). We discovered a significant enrichment in several GO terms and pathways associated with depression. CONCLUSION: Our findings showed the abnormal expression of ketamine-induced hippocampal circRNAs in rats.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Rno_circRNA_014900 and rno_circRNA_005442 emerged as potentially useful molecules in the treatment of stress-related depression.
“Rno_circRNA_014900 and rno_-circRNA_005442 emerged as potentially useful molecules in the treatment of stress-related depression [81].”
From Circular RNAs in depression: Biogenesis, function, expression, and therapeutic potential (2021) · cites this paper as [81]
rno_circRNA_005442 is downregulated in rat hippocampus.
“| 22 | rno_circRNA_005442 | - | Rat | | √ | Hippocampus | [81] |”
From Circular RNAs in depression: Biogenesis, function, expression, and therapeutic potential (2021) · cites this paper as [81]
rno_circRNA_014900 is upregulated in rat hippocampus.
“| 21 | rno_circRNA_014900 | - | Rat | √ | | Hippocampus | [81] |”
From Circular RNAs in depression: Biogenesis, function, expression, and therapeutic potential (2021) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Circular RNAs are abundant, conserved, and associated with ALU repeats
Jeck, W. R., Sorrentino, J. A., Wang, K., Slevin, M. K., Burd, C. E., Liu, J., Marzluff, W. F., & Sharpless, N. E. (2013) · RNA · doi:10.1261/rna.035667.112 · Cited by 4,388 · see citing works
The multilayered complexity of ceRNA crosstalk and competition
Tay, Y., Rinn, J., & Pandolfi, P. P. (2014) · Nature · doi:10.1038/nature12986 · Cited by 3,910 · see citing works
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · see citing works
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115 · see citing works
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651 · see citing works
Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Iqbal, S., Pillemer, S., Foulkes, A., Shah, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13030392 · Cited by 1,205 · see citing works
Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis
Newcomer, J. W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00067-0 · Cited by 604 · see citing works
Garcia, L. S. B., Comim, C. M., Valvassori, S. S., Réus, G. Z., Barbosa, L. M., Andreazza, A. C., Stertz, L., Fries, G. R., Gavioli, E. C., Kapczinski, F., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.027 · Cited by 454 · see citing works
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., & Levitt, P. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000866 · Cited by 446 · see citing works
Ketamine and the next generation of antidepressants with a rapid onset of action
Machado‐Vieira, R., Salvadore, G., Diazgranados, N., & Zarate, C. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.010 · Cited by 275 · see citing works
Yang, J., Wang, N., Yang, C., Shi, J., Yu, H., & Hashimoto, K. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.06.021 · Cited by 201 · see citing works
Wang, X., Chen, Y., Zhou, X., Liu, F., Zhang, T., & Zhang, C. (2012) · Journal of Ect · doi:10.1097/yct.0b013e31824d1d02 · Cited by 157 · see citing works
Self-citationCircular RNAs: Novel Regulators of Neuronal Development
van Rossum, D., Verheijen, B. M., & Pasterkamp, R. J. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00074 · Cited by 137 · see citing works
Pazini, F. L., Cunha, M. P., Rosa, J. M., Colla, A. R. D. S., Lieberknecht, V., Oliveira‐Giacomelli, Á., & Rodrigues, A. L. S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9580-9 · Cited by 132 · see citing works
Shi, H., Zhu, W., Liu, J., Luo, Y., Si, J., Wang, S., Xue, Y.-X., Ding, Z., Shi, J., & Lü, L. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.131 · Cited by 96 · see citing works
Sun, H.-L., Zhou, Z.-Q., Zhang, G.-F., Yang, C., Wang, X.-M., Shen, J.-C., Hashimoto, K., & Yang, J.-J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.21 · Cited by 84 · see citing works
Self-citationStratinaki, M., Varidaki, A., Mitsi, V., Ghose, S., Magida, J., Dias, C., Russo, S. J., Vialou, V., Caldarone, B. J., Tamminga, C. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214696110 · Cited by 82 · see citing works
The antidepressant roles of Wnt2 and Wnt3 in stress-induced depression-like behaviors
Zhou, W.-J., Xu, N., Kong, L., Sun, S.-C., Xu, X.-F., Jia, M.-Z., Wang, Y., & Chen, Z.-Y. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.122 · Cited by 70 · see citing works
Yang, X., Yang, Q., Wang, X., Luo, C., Wan, Y., Li, J., Liu, K., Zhou, M., & Zhang, C. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8312-z · Cited by 69 · see citing works
Self-citationCunha, M. P., Budni, J., Ludka, F. K., Pazini, F. L., Rosa, J. M., Oliveira‐Giacomelli, Á., Lopes, M. W., Tasca, C. I., Leal, R. B., & Rodrigues, A. L. S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9192-4 · Cited by 67 · see citing works
Martin, P.-M., Stanley, R., Ross, A. P., Freitas, A. E., Moyer, C. E., Brumback, A. C., Iafrati, J., Stapornwongkul, K. S., Domínguez, S. L., Kivimäe, S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.184 · Cited by 60 · see citing works
Malki, K., Tosto, M. G., Jumabhoy, I., Lourdusamy, A., Sluyter, F., Craig, I., Uher, R., McGuffin, P., & Schalkwyk, L. C. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.154 · Cited by 55 · see citing works
Zhou, W., Dong, L., Wang, N., Shi, J., Yang, J., Zuo, Z., & Zhou, Z. (2014) · NeuroImmunoModulation · doi:10.1159/000356517 · Cited by 49 · see citing works
Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach
Grados, M. A., Specht, M. W., Sung, H.-M., & Fortune, D. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.845553 · Cited by 49 · see citing works
MAP1B‐dependent Rac activation is required for AMPA receptor endocytosis during long‐term depression
Benoist, M., Palenzuela, R., Rozas, C., Rojas, P., Tortosa, E., Morales, B., González-Billault, C. E., Ávila, J., & Esteban, J. A. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.166 · Cited by 47 · see citing works
Nätt, D., Johansson, I., Faresjö, T., Ludvigsson, J., & Thorsell, A. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0123-z · Cited by 43 · see citing works
Antidepressant-like effect of valproic acid—Possible involvement of PI3K/Akt/mTOR pathway
Lima, I. V. D. A., Almeida-Santos, A. F., Ferreira-Vieira, T. H., de Aguiar, D. C., Ribeiro, F. M., Campos, A. C., & de Oliveira, A. C. P. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.015 · Cited by 43 · see citing works
Wang, M., Su, P., Liu, Y., et al. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10521 · Cited by 42 · see citing works
Ni, X., Liao, Y., Li, L., Zhang, X., & Wu, Z. (2018) · Journal of Integrative Neuroscience · doi:10.31083/jin-170052 · Cited by 37 · see citing works
High-resolution chromosome ideogram representation of recognized genes for bipolar disorder
Douglas, L. N., McGuire, A., Manzardo, A. M., & Butler, M. G. (2016) · Gene · doi:10.1016/j.gene.2016.04.011 · Cited by 26 · see citing works
Ni, X., Liao, Y., Li, L., Zhang, X., & Wu, Z. (2018) · Journal of Integrative Neuroscience · doi:10.3233/jin-170052 · Cited by 26 · see citing works
Microarray Analysis of the Major Depressive Disorder mRNA Profile Data
Gao, L., Gao, Y., Xu, E., & Xie, J. M. (2015) · Psychiatry Investigation · doi:10.4306/pi.2015.12.3.388 · Cited by 22 · see citing works
Zeng, D., Shen, H., Yu, S., Li, G., Ma, C., Wen, Y., Shen, Y., Yu, Y., & Li, H. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s155076 · Cited by 15 · see citing works
Kim, J., Lee, S., Kang, S., Jeon, T.-I., Kang, M., Lee, T., Kim, Y. S., Kim, K.-S., Im, H., & Moon, C. (2018) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2018.0023 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Yuan, M., Yang, B., Rothschild, G., Mann, J. J., Sanford, L. D., Tang, X., Huang, C., Wang, C., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01519-z · Cited by 246 · see citing works
Eigenhuis, E., Waumans, R. C., Muntingh, A. D. T., Westerman, M. J., van Meijel, M., Batelaan, N. M., & van Balkom, A. J. L. M. (2021) · PLOS ONE · doi:10.1371/journal.pone.0247516 · Cited by 90 · see citing works
Yusefi, A. R., Sharifi, M., Nasabi, N. S., Rezabeigi Davarani, E., & Bastani, P. (2022) · PLOS ONE · doi:10.1371/journal.pone.0262887 · Cited by 76 · see citing works
Circular RNAs in depression: Biogenesis, function, expression, and therapeutic potential
Gan, H., Lei, Y., Yuan, N., Tang, K., Hao, W., Ma, Q., Wu, M., Zhou, X., Li, X., Huang, J., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111244 · Cited by 41 · see citing works
Epigenetic Mechanisms of Rapid-Acting Antidepressants
Inserra, A., Campanale, A., Rezai, T., Romualdi, P., & Rubino, T. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03055-y · Cited by 27 · see citing works
Short video addiction scale for middle school students: development and initial validation
Ye, J., Wang, W., Huang, D., Ma, S., Chen, S., Dong, W., & Zhao, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-92138-x · Cited by 20 · see citing works
- Authors
- Mao, J., Li, T., Fan, D., Zhou, H., Feng, J., Liu, L., Zhang, C., & Wang, X.
- Affiliations
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
- University of Alabama at Birmingham (US)
- Corresponding author
- Wang, Xiaobin
- Venue
- BMC Psychiatry
- Published
- 2020-01-02
- Volume
- 20
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC6939336
- OpenAlex
- W3002516758
- Cited by
- 120
- References
- 34
- Citations by year
- 2026: 1 · 2025: 27 · 2024: 23 · 2023: 14 · 2022: 18 · 2021: 33 · 2020: 3
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- BMC Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Department of Science &Technology of Sichuan Province (14JC0093)
- the Projects of the National Natural Science Foundation of China (81271478)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Circular RNAs in diseases
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- circular RNA, ketamine, hippocampus, depression, antidepressant effects, microRNA binding sites, circRNA expression profiling, rat model
- MeSH terms
- RNA, Circular, Animals, Hippocampus, Ketamine, Male, Signal Transduction, Rats, Sprague-Dawley, Excitatory Amino Acid Antagonists, Computational Biology, Gene Expression Profiling, Rats, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review